EuroPCR 2018: SYNTAX II - Prof Patrick Serruys
EuroPCR 2018: SYNTAX III Revolution - Prof Patrick Serruys
SYNTAX II: iFR/FFR and IVUS-guided PCR and new-generation DES
SYNTAX II: 3 Year Outcome Results
SYNTAX II Trial: Introduction to Rationale
Let's move forward with evidence-based adult learning - EuroPCR 2018
SYNTAX II Trial: Role of Assessment in Multivessel Disease
SYNTAX I, SYNTAX II y SYNTAX III: Evaluación invasiva y no invasiva de la estenosis
EuroPCR 2018 Highlights - Coronary Interventions
EuroPCR 2018: Early clinical experience of NaviGate in transcatheter tricuspid valve replacement
Wrap Up Of EuroPCR 2018 - An Analysis Of The Late-Breaking Trials
PCR statement on Chronic Coronary Syndromes (CCS)
EuroPCR 2018: FAME 2 - Five-Year Outcomes - Dr Panagiotis Xaplanteris
SYNTAX II: IVUS Imaging in PCI
EuroPCR 2018: SCAAR - Prof Elmir Omerovic
CITIC - Episodio 1 - Me Marcó el Syntax II
CCI Editor's Choice Article (September 2013): Impact of Incomplete Revascularization
Prof. Patrick Serruys presenting breakthrough Talent Late breaking trial result at TCT 2018
David Taggart - Lessons from the SYNTAX trial.
Complex double stent techniques in left main disease - PCR Round Table Webinar
SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI | Prof Adrian Banning
EuroPCR 2018: SURTAVI - Prof Patrick Serruys
The ORBITA trial - EuroPCR 2018
Physiology guided PCI in bifurcations - Round Table Webinar
SYNTAX II Trial: Complex PCI Case in a High-Risk Patient
